Chemical signatures and new drug targets for gametocytocidal drug development
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chemical signatures and new drug targets for gametocytocidal drug development
Authors
Keywords
-
Journal
Scientific Reports
Volume 4, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-01-17
DOI
10.1038/srep03743
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterization of Torin2, an ATP-Competitive Inhibitor of mTOR, ATM, and ATR
- (2013) Q. Liu et al. CANCER RESEARCH
- First-in-Human Phase I Dose-Escalation Study of the HSP90 Inhibitor AUY922 in Patients with Advanced Solid Tumors
- (2013) C. Sessa et al. CLINICAL CANCER RESEARCH
- A quantitative high throughput assay for identifying gametocytocidal compounds
- (2013) Takeshi Q. Tanaka et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Torins are potent antimalarials that block replenishment of Plasmodium liver stage parasitophorous vacuole membrane proteins
- (2013) K. K. Hanson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transmission-blocking interventions eliminate malaria from laboratory populations
- (2013) A. M. Blagborough et al. Nature Communications
- Development and Optimization of a Novel 384-Well Anti-Malarial Imaging Assay Validated for High-Throughput Screening
- (2012) Sandra Duffy et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Whole-cellin vitroscreening for gametocytocidal compounds
- (2012) Leonardo Lucantoni et al. Future Medicinal Chemistry
- Effects of Antimalarial Molecules on the Gametocyte Stage of Plasmodium falciparum: The Debate
- (2012) Odile Dechy-Cabaret et al. JOURNAL OF MEDICINAL CHEMISTRY
- Comparative Gene Expression Profiling of P. falciparum Malaria Parasites Exposed to Three Different Histone Deacetylase Inhibitors
- (2012) Katherine T. Andrews et al. PLoS One
- Liver-stage malaria parasites vulnerable to diverse chemical scaffolds
- (2012) E. R. Derbyshire et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Phase I Study of the Heat Shock Protein 90 Inhibitor Alvespimycin (17-DMAG) Given Intravenously to Patients with Advanced Solid Tumors
- (2011) Simon Pacey et al. CLINICAL CANCER RESEARCH
- Targeting FK506 Binding Proteins to Fight Malarial and Bacterial Infections:Current Advances and Future Perspectives
- (2011) N. Bharatham et al. CURRENT MEDICINAL CHEMISTRY
- A High-Throughput Screen Targeting Malaria Transmission Stages Opens New Avenues for Drug Development
- (2011) Kathrin Buchholz et al. JOURNAL OF INFECTIOUS DISEASES
- Discovery of 9-(6-Aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a Potent, Selective, and Orally Available Mammalian Target of Rapamycin (mTOR) Inhibitor for Treatment of Cancer
- (2011) Qingsong Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania
- (2011) Seif A Shekalaghe et al. MALARIA JOURNAL
- A high-throughput assay for the identification of drugs against late-stage Plasmodium falciparum gametocytes
- (2011) Christopher L. Peatey et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- A malaria gametocytocidal assay using oxidoreduction indicator, alamarBlue
- (2011) Takeshi Q Tanaka et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Chemical Genomic Profiling for Antimalarial Therapies, Response Signatures, and Molecular Targets
- (2011) J. Yuan et al. SCIENCE
- The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics
- (2011) R. Huang et al. Science Translational Medicine
- CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer Activity
- (2010) Cheng-Jung Lai et al. CANCER RESEARCH
- An essential Aurora-related kinase transiently associates with spindle pole bodies during Plasmodium falciparum erythrocytic schizogony
- (2010) Luc Reininger et al. MOLECULAR MICROBIOLOGY
- Thousands of chemical starting points for antimalarial lead identification
- (2010) Francisco-Javier Gamo et al. NATURE
- Chemical genetics of Plasmodium falciparum
- (2010) W. Armand Guiguemde et al. NATURE
- Consideration of ethics in primaquine therapy against malaria transmission
- (2010) J. Kevin Baird et al. TRENDS IN PARASITOLOGY
- Small molecules and targeted therapies in distant metastatic disease
- (2009) P. Hersey et al. ANNALS OF ONCOLOGY
- Effect of Antimalarial Drugs onPlasmodium falciparumGametocytes
- (2009) Christopher L. Peatey et al. JOURNAL OF INFECTIOUS DISEASES
- Malaria: a research agenda for the eradication era
- (2009) Wen Kilama et al. LANCET
- Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum
- (2009) Jing Yuan et al. Nature Chemical Biology
- Strong Gametocytocidal Effect of Methylene Blue-Based Combination Therapy against Falciparum Malaria: A Randomised Controlled Trial
- (2009) Boubacar Coulibaly et al. PLoS One
- Target identification using drug affinity responsive target stability (DARTS)
- (2009) B. Lomenick et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NVP-AUY922: A Novel Heat Shock Protein 90 Inhibitor Active against Xenograft Tumor Growth, Angiogenesis, and Metastasis
- (2008) S. A. Eccles et al. CANCER RESEARCH
- In silicoactivity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen
- (2008) David Plouffe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started